English | Español
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck
Patient Daily | Feb 5, 2026

Study finds tertiary treatment reduces antibiotic resistance transfer from reclaimed irrigation water
Patient Daily | Feb 5, 2026

Review highlights possible link between microplastics exposure and Parkinson’s disease mechanisms
Patient Daily | Feb 5, 2026

Canadian study finds no adverse effects from daily full-fat dairy consumption in overweight adults
Patient Daily | Feb 5, 2026

Study links high-iron environments to persistent but less damaging Pseudomonas lung infections
Patient Daily | Feb 5, 2026

Editorial discusses promise of GLP‑1 drugs for reducing deaths among people with serious mental illness
Patient Daily | Feb 5, 2026

Review finds links between gut microbiome changes and Alzheimer’s progression

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science